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Objective: The mortality for acute myocardial
infarction (AMI) has declined worldwide. However,
improvements in care for AMI in South Korea have
lagged slightly behind those in other countries.
Therefore, it is important to investigate how factors
such as hospital volume, structural characteristics of
hospital and hospital staffing level affect 30-day
mortality due to AMI in South Korea.
Setting: We used health insurance claim data from
114 hospitals to analyse 30-day mortality for AMI.
Participants: These data consisted of 19 638
hospitalisations during 2010–2013.
Interventions: No interventions were made.
Outcome measure: Multilevel models were analysed
to examine the association between the 30-day
mortality and inpatient and hospital level variables.
Results: In the 30 days after hospitalisation, 10.5% of
patients with AMI died. Hospitalisation cases at
hospitals with a higher AMI volume had generally
inverse associations with 30-day mortality (1st
quartile=ref; 2nd quartile=OR 0.811, 95% CI 0.658 to
0.998, 3rd quartile=OR 0.648, 95% CI 0.500 to 0.840,
4th quartile=OR 0.807, 95% CI 0.573 to 1.138).
In addition, hospitals with a greater proportion of
specialists were associated with better outcomes
(above median=OR 0.789, 95% CI 0.663 to 0.940).
Conclusions: Health policymakers need to include
volume and staffing when defining the framework for
treatment of AMI in South Korean hospitals. Otherwise,
they must consider increasing the proportion of
specialists or regulating the hiring of emergency
medicine specialists. In conclusion, they must make an
effort to reduce 30-day mortality following AMI based
on such considerations.
INTRODUCTION
Acute myocardial infarction (AMI) occurs
when blood ﬂow to the heart is severely
reduced or cut-off completely. AMI often
strikes with no warning, as atherosclerosis, a
sentinel cause of AMI, has no symptoms.1
Consequently, until recently, AMI led to high
mortality worldwide.
Developments in medical technology and
clinician guidelines2 3 have led to consistent
declines in worldwide AMI mortality. In
South Korea, improvements in care for AMI
have been reported since 2007 when
an initial evaluation project began.4
Nevertheless, 30-day mortality after AMI hos-
pitalisation, which provides good indications
of acute care quality, is higher in South
Korea than in other Organization for
Economic Co-operation and Development
(OECD) countries (OECD average: 10.8
deaths/100 patients; South Korea: 11.2
deaths/100 patients).5 Moreover, ischaemic
heart disease, including AMI, is still a major
cause of death all over the world (7.4 million
deaths in 2012, accounting for 13.2% of all
deaths).6
Many studies on factors related to 30-day
AMI mortality have been conducted in the
past. Some have found that hospitals with
higher AMI volumes have lower mortality, as
volume leads to the mastery of speciﬁc
Strengths and limitations of this study
▪ Our results provide the government with a poten-
tial solution for controlling outcomes in patients
with acute myocardial infarction.
▪ Our models considered the hierarchical nature of
claim data, capturing the diversity of inpatients
and hospitals as much as possible.
▪ We only included 156 hospitals in this study, as
the national health insurance claim data we used
did not include data from all hospitals in South
Korea due to access authority and ethical issues.
▪ We were unable to determine whether the same
inpatients were hospitalised multiple times, as
the data used in our study were based on only
hospitalisation cases.
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treatments.7–12 In addition, previous studies have shown
that 30-day AMI mortality is associated with patient and
hospital characteristics, such as length of stay, sex, type
of insurance coverage, age, hospital ownership status,
etc.13–19
To date, some studies have examined the relationship
between outcomes in AMI and clinical factors as surgery
and procedure, but there are a few studies which exam-
ined the relationship between 30-day AMI mortality and
hospital characteristics in South Korea. Therefore, it is
important to explore how factors such as hospital
volume and stafﬁng level affect 30-day mortality after
AMI in South Korean hospitals. We investigated the rela-
tionship between 30-day AMI mortality and hospital
volume, as well as other characteristics. In particular, we
analysed the effect of the number of emergency and car-
diothoracic medicine specialists present.
MATERIALS AND METHODS
Data source
The data used in this study was a proportion of the
National Health Insurance (NHI) Claim data. After the
introduction of the National Health Insurance Services
(NHIS) in 1989, medical records of each patient could
be collected by the South Korean government. These
types of data included information about patients’ util-
isation of healthcare resources based on their needs,
and these data also collected information about hospi-
tals which each patient visited. In addition, data used in
this study could consider details about death by being
merged with mortality data based on personal identiﬁca-
tion codes in the national database, as well as both
patient-level and hospital-level characteristics. Although
it would have been ideal had we been able to use data
from all hospitals in South Korea, there were some difﬁ-
culties in accessing patient information due to issues
such as ethics. Therefore, we needed to extract represen-
tative hospital samples from all hospitals effectively.
However, in this process, there were some limitations in
linking each patient and each hospitalisation case using
the encrypted information because data are provided
after extraction from the national database due to
ethical issues, making it impossible to identify each
patient afterwards.
Study population
There were about 1730 hospitals (including 39 public
hospitals) in operation during 2010–2013 in South
Korea. Given that the number of public hospitals was
just 39 among the total 1730 hospitals in South Korea,
we assumed that it could cause baseline imbalances due
to differences in hospital characteristics. Thus, the pro-
pensity score matching was used to reduce bias caused
by the observed covariates and to deal with the usual
baseline imbalances across hospitals.20 Therefore, we
included 156 hospitals (117 private and 39 public) that
were determined using propensity score-matching
methods (1:3 ratio of public hospitals vs private hospi-
tals), adjusting for region, nurse stafﬁng level, number
of total beds, number of intensive care unit (ICU) beds,
number of emergency room (ER) beds and number of
doctors. In the propensity score-matching methods, the
outcome variable is propensity score. The propensity
score is the probability of a unit being assigned to a par-
ticular treatment given a set of observed covariates. On
the basis of these scores, we matched each sample using
the nearest neighbour methods.21 Among these 156 hos-
pitals, we excluded those without AMI inpatient cases
(N=42). Ultimately, 114 hospitals (31 public and 83
private; 19 638 hospitalisation cases) were included for
analysis. The unit of analysis was each hospitalisation
rather than each patient.
Variables
The outcome variable in this study was death within
30-day of the date of each hospitalisation for AMI. The
data used in our study only consisted of hospitalisation
cases, although the details of the date of death were
included with each case. We identiﬁed each hospitalisa-
tion’s ﬁrst date of admission in the calendar year during
the study period as the index date. If the date of death
for each hospitalisation case was included within 30 cal-
endar days of the index date, the case was classiﬁed as
mortality within 30-day. Thus, the outcome variable in
this study was 30-day mortality after admission, including
both in-hospital mortality and mortality after discharge.
The primary variables of interest in relation to death
within 30-day of hospitalisation were hospital volume
and other hospital characteristics. Before analysing the
data, we ﬁrst tested whether hospital variables achieved
assumptions of normality or linearity, and then we
decided to categorise hospital variables on the basis of
the results of these tests. The number of hospitalisation
cases due to AMI (ie, hospital volume) was categorised
by quartile (25th quartile: 368, 50th quartile: 605, and
75% quartile: 1214). Hospital characteristics included
structural characteristics, such as the number of beds,
the number of ICU beds, the number of ER beds, teach-
ing status, ownership status and region, as well as human
resource variables, such as the proportion of specialists,
the number of cardiothoracic medicine specialists and
the number of emergency medicine specialists. The pro-
portion of specialists represents the number of specialists
divided by the total number of doctors, reﬂecting the
specialised expertise present in each hospital. These
variables were used after calculating mean values of each
hospital during the study period (2010–2013), and cate-
gorised by the median value of each variable based on
the tests for normality or linearity.
Additionally, our models included inpatient-level vari-
ables, such as major diagnosis, the Charlson
Comorbidity Index, type of insurance coverage, age and
year of hospitalisation. Major diagnoses were charac-
terised according to the International Classiﬁcation of
Diseases groupings (ICD-10: I21.0, I21.1, I21.2, I21.3,
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I21.4, I21.9) to reﬂect speciﬁc pathological mechanisms.
The Charlson Comorbidity Index was calculated on the
basis of whether a particular condition was present,
excluding the major symptom at the date of admission
to reﬂect the effect of comorbid disorders or diseases.
Type of insurance coverage was categorised as beneﬁciar-
ies of NHI or Medical Aid. Most of the general popula-
tion who were covered by the NHI after paying the
insurance fee charged on the basis of economic status
evaluation, whereas a few low-income, disabled and
elderly populations were covered by Medical Aid, being
offered free insurance by the government.22
Statistical analysis
We examined the distribution of each categorical vari-
able by examining frequencies and percentages and per-
formed χ2 tests to investigate the associations with 30-day
mortality. These analyses were performed for
inpatient-level and hospital-level variables. Next, we per-
formed hierarchical logistic regression analysis using
multilevel models with the Generalized Linear Mixed
Model (GLIMMIX) procedure including inpatient-level
and hospital-level variables, analysed to examine the
associations with 30-day mortality after hospitalisation.
Additionally, subgroup analyses for multilevel models
were performed according to the median number of
specialists in emergency or cardiothoracic medicine.
These were also performed after stratifying on the basis
of regional hospital characteristics. All statistical analyses
were performed using SAS statistical software V.9.2. All
p values calculated were two-sided and considered
signiﬁcant at p<0.05.
RESULTS
The data used in this analysis consisted of 19 638 hospi-
talisations. Of these, 17 605 inpatients (89.5%) survived,
and 2033 (10.5%) died within 30-day after the date of
each admission. Table 1 shows the univariate associations
between independent variables and 30-day mortality due
to AMI. In terms of detailed major diagnoses, ‘Acute
transmural myocardial infarction of inferior wall
(ICD-10: I21.1)’ was associated with the lowest 30-day
mortality rate after AMI hospitalisation (5.5%). Lower
Charlson Comorbidity Index scores were associated with
higher 30-day survival rates (score=0: 2.7%, score=1:
2.7%, score=2: 4.7%, score=3+: 15.4%). The 30-day mor-
tality rate for males (7.6%) was lower than that for
females (16.4%). Finally, inpatients of the general popu-
lation, who were covered by national health insurance,
had lower mortality than beneﬁciaries of Medical Aid,
which provides free inpatient and outpatient care for
the low-income, disabled and elderly populations by
using government funds (NHI: 9.9%, Medical Aid:
15.4%). In the distribution of hospital-level variables,
141 hospitals were used in this study. Regarding the
results of hospital volume due to AMI, hospitals with
higher AMI volumes were associated with lower 30-day
mortality (1st quartile: 17.8%, 2nd quartile: 8.9%, 3rd
quartile: 7.9%, 4th quartile: 7.3%; p<0.001). However,
hospitals scoring below the median for the proportion
of specialists were shown less frequently in 30-day mortal-
ity due to AMI than those above the median (below
median: 8.4%, above median: 12.3%). In terms of hos-
pital stafﬁng, hospitals with a higher number of cardio-
thoracic medicine or emergency medicine specialists
were associated with lower 30-day mortality. On the basis
of ownership or teaching status, private or non-teaching
hospitals were shown less frequently in 30-day mortality
than other types of hospitals (table 1).
Next, we performed hierarchical logistic regression
analysis using a multilevel model adjusting for
inpatient-level and hospital-level variables to investigate
the relationships with 30-day mortality in inpatients with
AMI. The results revealed that inpatients with a diagno-
sis of ‘acute transmural myocardial infarction of unspeci-
ﬁed sites (ICD-10: I21.4)’ had the highest risk of death
in the ﬁrst 30-days following AMI hospitalisation com-
pared with inpatients with AMI of the inferior wall (OR
2.451, 95% CI 1.729 to 3.475). Hospitalisation cases with
higher than three Charlson Comorbidity Index scores
were also associated with a higher risk of 30-day mortal-
ity. Additionally, females had a higher risk of 30-day mor-
tality than males. Finally, inpatients aged ≥65 years also
had a higher 30-day risk of death. In terms of hospital-
level variables, hospitalisation cases at hospital with a
higher AMI volume had generally inverse associations
with 30-day mortality (1st quartile=ref; 2nd quartile=OR
0.811, 95% CI 0.658 to 0.998, 3rd quartile=OR 0.648,
95% CI 0.500 to 0.840, 4th quartile=OR 0.807, 95% CI
0.573 to 1.138). Also, hospitalisation cases at hospitals
with a greater proportion of specialists were also asso-
ciated with a lower mortality risk (OR 0.789, 95% CI
0.663 to 0.940). Similarly, hospitalisation cases at hospi-
tals with more emergency medicine specialists had a
lower level of 30-day mortality. With regard to structural
characteristics, hospitalisation cases at teaching hospitals
had a lower mortality risk than those at non-teaching
hospitals. In addition, cases at private hospitals had a
lower risk of 30-day following hospitalisation due to AMI.
With regard to the regional characteristics of hospitals,
hospitals in non-metropolitan regions had an inverse
association with 30-day mortality (table 2).
We performed additional analysis for hierarchical
logistic regression analysis using a multilevel model to
investigate the differences in association with 30-day
mortality after stratifying by the median number of spe-
cialists in emergency and cardiothoracic medicine,
respectively. A similar analysis was also performed after
stratifying by regional hospital characteristics. The
overall trends in the subgroup analyses were similar to
the results in the full model analyses. There were some
differences related to hospital volume or stafﬁng. In the
results of the subgroup analysis by median value of
emergency or cardiothoracic medicine, hospitals with a
higher AMI volume were inversely associated with 30-day
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Table 1 Associations between inpatient or hospital characteristics and 30-day mortality after AMI hospitalisation
Variables
Survived Died
p ValueN Per cent N Per cent
Inpatient-level variables
Major diagnosis
Acute transmural myocardial infarction of anterior wall 1748 92.5 141 7.5 <0.0001
Acute transmural myocardial infarction of inferior wall 1451 94.5 85 5.5
Acute transmural myocardial infarction of other sites 212 88.3 28 11.7
Acute transmural myocardial infarction of unspecified sites 1836 91.2 178 8.8
Acute subendocardial myocardial infarction 3895 93.3 279 6.7
Acute myocardial infarction, unspecified 8463 86.5 1322 13.5
Charlson Comorbidity Index
0 1594 97.3 45 2.7 <0.0001
1 3134 97.3 87 2.7
2 3321 95.3 165 4.7
3+ 9556 84.6 1736 15.4
Sex
Male 12 419 92.4 1018 7.6 <0.0001
Female 5186 83.6 1015 16.4
Type of insurance coverage
NHI 16 129 90.1 1764 9.9 <0.0001
Medical Aid 1476 84.6 269 15.4
Year of hospitalisation
2010 2640 88.6 340 11.4 0.1240
2011 5503 89.9 621 10.1
2012 6113 90.1 672 9.9
2013 3349 89.3 400 10.7
Age (years)
<65 8898 96.6 312 3.4 <0.0001
≥65 8707 83.5 1721 16.5
Hospital-level variables
Hospital volume
1st quartile (<368 cases; 92 hospitals) 3950 82.2 858 17.8 <0.0001
2nd quartile (368–604 cases; 10 hospitals) 3721 91.1 363 8.9
3rd quartile (605–1213 cases; 8 hospitals) 4600 92.1 394 7.9
4th quartile (≥1214 cases≥; 4 hospitals) 5334 92.7 418 7.3
Specialist proportion
Below median (<58.62%; 18 hospitals) 9094 91.6 835 8.4 <0.0001
Above median (≥58.62%; 96 hospitals) 8511 87.7 1198 12.3
Number of cardiothoracic medicine specialists
Below median (<3; 98 hospitals) 7678 86.7 1181 13.3 <0.0001
Above median (≥3; 16 hospitals) 9927 92.1 852 7.9
Number of emergency medicine specialists
Below median (<5; 95 hospitals) 7590 86.3 1206 13.7 <0.0001
Above median (≥5; 19 hospitals) 10 015 92.4 827 7.6
Number of beds
Below median (<617; 100 hospitals) 7768 86.4 1227 13.6 <0.0001
Above median (≥617; 14 hospitals) 9837 92.4 806 7.6
Number of ICU beds
Below median (<49; 101 hospitals) 7925 86.2 1271 13.8 <0.0001
Above median (≥49; 13 hospitals) 9680 92.7 762 7.3
Number of ER beds
Below median (<30; 99 hospitals) 7785 86.2 1247 13.8 <0.0001
Above median (≥30; 15 hospitals) 9820 92.6 786 7.4
Teaching status
Non-teaching hospital (71 hospitals) 15 475 91.2 1491 8.8 <0.0001
Teaching hospital (43 hospitals) 2130 79.7 542 20.3
Ownership
Public (31 hospitals) 1145 79.2 301 20.8 <0.0001
Private (83 hospitals) 16 460 90.5 1732 9.5
Continued
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mortality in only the below median group. However,
there were no statistically signiﬁcant differences in the
above median group in both analyses (ﬁgures 1 and 2).
In the subgroup analysis by regional characteristics,
there were differences in the relationship between hos-
pital volume and stafﬁng and 30-day mortality.
Hospitalisation cases with a higher AMI volume were
associated with a lower risk of 30-day mortality in only
non-metropolitan areas. In addition, lower 30-day mor-
tality was associated with a higher proportion of specia-
lists, but this relationship was also statistically signiﬁcant
in only non-metropolitan regions (ﬁgure 3).
DISCUSSION
We analysed the relationships between the 30-day mor-
tality after hospitalisation for AMI and hospital volume,
structural characteristics and hospital stafﬁng level to
establish which factors affect AMI mortality. Our results
indicate that higher AMI volume is associated with
better outcomes, most likely because high volume for a
speciﬁc disease increases expertise.23–26 In addition,
better outcomes were associated with a greater propor-
tion of specialists and a higher number of emergency
medicine physicians. These factors are typically asso-
ciated with better quality of care.27–29 Many previous
analyses on hospital volume, structural characteristics,
etc have been conducted.
However, our study has several strengths compared
with previous studies. First, we conducted a multilevel
analysis using national health insurance claim data that
reﬂected inpatient and hospital characteristics. Thus,
our models considered the hierarchical nature of claim
data, capturing the diversity of inpatients and hospitals
as much as possible. Second, our study considered the
hospital stafﬁng level, including the proportion of spe-
cialists and number of emergency medicine specialists
and cardiothoracic specialists. Of course, studies report-
ing better AMI outcomes in association with the pres-
ence of specialists have been published in the past,27 30
using cardiologists as a proxy for AMI surgery expert-
ise.31 32 However, we included the number of emergency
medicine specialists in our analysis, as it is very import-
ant to treat inpatients with AMI quickly and most are
hospitalised via the ER.33–35 Our results emphasise the
need for emergency medicine specialists in acute care,
suggesting that it is needed to improve not only quantity
of hospital stafﬁng but also quality of those for effective
care in the management of inpatients with AMI.
Unfortunately, hospitals have not yet been able to suc-
cessfully address the lack of emergency medicine specia-
lists in the current business climate.36–38 We also
analysed the proportion of specialists in our study,
obtaining results similar to those reported in other
studies.17 39 However, our study considered the relative
number of specialists rather than the absolute number,
using proportion. Collectively, our ﬁndings suggest that
improvements be made to hospitals’ human resource
pool, which will create an economic burden and chal-
lenge policymakers and hospital managers. Third, we
considered hospital characteristics such as ownership
and teaching status. Our results, similar to those in previ-
ous studies,40 indicate that private hospitals have better
outcomes. There were some concerns that the differ-
ences in outcomes by ownership status might have been
affected by differences in the proportion of medical aid
beneﬁciaries due to unmeasured bias. Nevertheless,
better quality management in public hospitals seems
necessary, though a clear assessment of quality is essen-
tial before management changes are initiated. Some
hospitals, for example, may appear to have worse out-
comes than others simply due to a failure to properly
adjust for the inpatient mix. Finally, we performed sub-
group analysis by median values for emergency medicine
or cardiothoracic medicine specialists in hospital. In the
results of the analyses, higher hospital volume was more
signiﬁcantly associated with a lower risk in 30-day mortal-
ity in only the below median group for emergency or
cardiothoracic medicine specialists. These ﬁndings
suggest that a higher volume could result in an increase
in expertise in managing AMI in hospitals without
either emergency or cardiothoracic medicine specialists.
Conversely, hiring more specialists in either emergency
or cardiothoracic medicine would be an efﬁcient strat-
egy for the management of patients with AMI in hospi-
tals without higher hospital volume. In addition, the
results of the subgroup analysis by region indicated a
volume-outcome relationship in only non-metropolitan
regions, as hospitals in metropolitan regions had already
reached sufﬁcient expertise due to the presence of more
specialists and sufﬁcient hospital volume of visiting
patients.
Our study also has several limitations. First, we only




p ValueN Per cent N Per cent
Region
Metropolitan (36 hospitals) 6109 88.3 810 11.7 <0.0001
Others (78 hospitals) 11 496 90.4 1223 9.6
Total 17 605 89.5 2033 10.5
AMI, acute myocardial infarction; ER, emergency room; ICU, intensive care unit; NHI, National Health Insurance.
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Table 2 Factors associated with 30-day mortality after AMI hospitalisation, according to a multilevel model
Variables OR 95% CI
Inpatient-level variables
Major diagnosis
Acute transmural myocardial infarction of anterior wall 1.463 1.039 2.061
Acute transmural myocardial infarction of inferior wall 1.000 – –
Acute transmural myocardial infarction of other sites 2.032 1.062 3.887
Acute transmural myocardial infarction of unspecified sites 2.451 1.729 3.475
Acute subendocardial myocardial infarction 1.190 0.866 1.637
Acute myocardial infarction, unspecified 1.986 1.494 2.640
Charlson Comorbidity Index
0 1.000 – –
1 1.045 0.657 1.663
2 0.985 0.621 1.562
3+ 2.016 1.293 3.143
Sex
Male 1.000 – –
Female 1.426 1.244 1.635
Type of insurance coverage
NHI 1.000 – –
Medical Aid 1.222 0.998 1.497
Age (years)
<65 1.000 – –
≥65 3.359 2.724 4.141
Year of hospitalisation
2010 1.000 – –
2011 0.790 0.646 0.965
2012 0.770 0.633 0.936
2013 0.813 0.654 1.011
Hospital-level variables
Hospital volume
1st quartile (<368 cases; 92 hospitals) 1.000 – –
2nd quartile (368–604 cases; 10 hospitals) 0.811 0.658 0.998
3rd quartile (605–1213 cases; 8 hospitals) 0.648 0.500 0.840
4th quartile (≥1214 cases≥; 4 hospitals) 0.807 0.573 1.138
Specialist proportion
Below median (<58.62%; 18 hospitals) 1.000 – –
Above median (≥58.62%; 96 hospitals) 0.789 0.663 0.940
Number of cardiothoracic medicine specialists
Below median (<3; 98 hospitals) 1.000 – –
Above median (≥3; 16 hospitals) 1.013 0.842 1.219
Number of emergency medicine specialists
Below median (<5; 95 hospitals) 1.000 – –
Above median (≥5; 19 hospitals) 0.760 0.619 0.933
Number of beds
Below median (<617; 100 hospitals) 1.000 – –
Above median (≥617; 14 hospitals) 0.882 0.677 1.151
Number of ICU beds
Below median (<49; 101 hospitals) 1.000 – –
Above median (≥49; 13 hospitals) 1.091 0.861 1.383
Number of ER beds
Below median (<30; 99 hospitals) 1.000 – –
Above median (≥30; 15 hospitals) 0.862 0.693 1.073
Teaching status
Non-teaching hospital (71 hospitals) 1.000 – –
Teaching hospital (43 hospitals) 0.716 0.570 0.900
Ownership
Public (31 hospitals) 1.000 – –
Private (83 hospitals) 0.781 0.626 0.976
Continued
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health insurance claim data we used did not include
data from all hospitals in South Korea due to access
authority and ethical issues. Therefore, we used the pro-
pensity score matching for effective data extraction. In
using such methodology, there were some concerns
related to the process of data extraction. In fact, it might
have been better to identify public hospitals that admit-
ted patients with AMI and then randomly sample private
hospitals, but we were unable to do so due to regulations
in the process of extracting data from the national data-
base. Thus, it may be difﬁcult to generalise our results to
South Korea as a whole. Second, we were unable to
determine whether the same inpatients were hospita-
lised multiple times, as the data used in our study were
based on only hospitalisation cases, not inpatient details.
The details of whether patients transferred to other hos-
pitals in order to receive better specialised care could
not be considered in this study, because those types of
information were unavailable in the data used in this
study. In addition, details on the procedures used, such
as angioplasty, percutaneous coronary intervention and
coronary artery bypass graft surgery, were not included
in the available data and therefore not considered in
our analysis, despite such information being an import-
ant indicator of AMI care quality. Third, we were unable
to analyse associations between AMI mortality and cardi-
ologist numbers, as the hospital stafﬁng level data used
in our study only included the number of cardiothoracic
and emergency medicine specialists and not the
number of cardiologists. Fourth, the data used in this
Table 2 Continued
Variables OR 95% CI
Region
Metropolitan (36 hospitals) 1.000 – –
Others (78 hospitals) 0.854 0.732 0.995
Statistically significant results are shown in bold typeface.
AMI, acute myocardial infarction; ICU, intensive care unit; NHI, National Health Insurance.
Figure 1 Factors associated with 30-day mortality after hospitalisation, stratified by median value of emergency medicine
specialists. The OR as marked as circle point was calculated by multilevel analysis adjusted for inpatient-level characteristics and
hospital-level characteristics, and results were statistically significant if each bar as marked to SD is not reached the cutoff line in
1.00. UCL=95% upper confidence limit, LCL=95% lower confidence limit.
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study could reﬂect information about patient-level
and hospital-level variables, because these data were
collected into the national database by NHIS. However,
we could not include all of the detailed factors such as
the distance to hospitals due to data limitations. Thus, it
may be difﬁcult to make strong conclusions solely on the
basis of our results. Additionally, we were unable to
determine the difference of the incremental relation-
ship per 1 unit increases by high or low numbers of car-
diothoracic or emergency medicine specialists, as the
range of data used in our study was too small to perform
an analysis. Finally, our study considered neither costs
nor readmissions. Therefore, future studies investigating
these issues are warranted.
Despite these limitations, our ﬁndings suggest that
inpatient-level and hospital-level factors have a substan-
tial impact on 30-day mortality after hospitalisation for
AMI, providing valuable information for health policy-
makers. In 2007, the South Korea government intro-
duced a programme designed to improve the
management of patients with AMI by assessing perform-
ance based on rates of reperfusion treatment, medica-
tion and survival. On the basis of the results of this
assessment, the government provided incentives or disin-
centives to hospitals. Although many previous studies
determined that higher hospital volume was associated
with better outcomes in the management of patients
with AMI, the programme did not reﬂect structural
characteristics including hospital stafﬁng and hospital
volume in evaluating the performance of each hospital.
Given that hospitals with a higher volume or a higher
proportion of specialists achieved better AMI care out-
comes in the results of our study, health policymakers
need to consider adding such indicators in performance
evaluation tools used in management programmes.
Otherwise, health policymakers must consider increasing
the proportion of specialists in hospitals, which would
include regulating the hiring of emergency medicine
specialists. In conclusion, health policymakers and hos-
pital managers must make an effort to reduce avoidable
AMI deaths based on such considerations.
CONCLUSIONS
Outcomes for AMI care were better in hospitals with
either a higher AMI volume or a higher proportion of
specialists. Speciﬁcally, hospitals that employed more
emergency medicine specialists had better AMI survival
rates. In addition, the reduction of risk for 30-day mor-
tality was better associated with the median value for
Figure 2 Factors associated with 30-day mortality after hospitalisation, stratified by median value of cardiothoracic medicine
specialists. The OR, marked by a circle, was calculated by multilevel analysis adjusted for inpatient-level characteristics and
hospital-level characteristics, and results were statistically significant if each bar as marked to SD has not reached the cutoff line
in 1.00. UCL=95% upper confidence limit, LCL=95% lower confidence limit.
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emergency or cardiothoracic medicine specialists,
respectively. These ﬁndings are likely to be helpful in
establishing a management strategy for patients with
AMI. Given that hospitals with higher volumes or a
higher proportion of specialists achieved better AMI
care outcomes in the results of our study, health policy-
makers need to consider adding such indicators in per-
formance evaluation tools used in management
programmes when creating effective alternative strat-
egies targeting to reduce avoidable deaths due to AMI.
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